HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.

Abstract
We present evidence here that exosomes stimulate aggregation of amyloid beta (Aβ)1-42 in vitro and in vivo and interfere with uptake of Aβ by primary cultured astrocytes and microglia in vitro. Exosome secretion is prevented by the inhibition of neutral sphingomyelinase 2 (nSMase2), a key regulatory enzyme generating ceramide from sphingomyelin, with GW4869. Using the 5XFAD mouse, we show that intraperitoneal injection of GW4869 reduces the levels of brain and serum exosomes, brain ceramide, and Aβ1-42 plaque load. Reduction of total Aβ1-42 as well as number of plaques in brain sections was significantly greater (40% reduction) in male than female mice. Our results suggest that GW4869 reduces amyloid plaque formation in vivo by preventing exosome secretion and identifies nSMase2 as a potential drug target in AD by interfering with exosome secretion.
AuthorsMichael B Dinkins, Somsankar Dasgupta, Guanghu Wang, Gu Zhu, Erhard Bieberich
JournalNeurobiology of aging (Neurobiol Aging) Vol. 35 Issue 8 Pg. 1792-800 (Aug 2014) ISSN: 1558-1497 [Electronic] United States
PMID24650793 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Amyloid beta-Peptides
  • Aniline Compounds
  • Benzylidene Compounds
  • Ceramides
  • GW 4869
  • Peptide Fragments
  • amyloid beta-protein (1-42)
  • Smpd3 protein, mouse
  • Sphingomyelin Phosphodiesterase
Topics
  • Alzheimer Disease (etiology, metabolism, therapy)
  • Amyloid beta-Peptides (metabolism)
  • Aniline Compounds (pharmacology)
  • Animals
  • Astrocytes (metabolism)
  • Benzylidene Compounds (pharmacology)
  • Brain (metabolism)
  • Cells, Cultured
  • Ceramides (metabolism)
  • Disease Models, Animal
  • Exosomes (metabolism)
  • Female
  • Male
  • Mice, Inbred C57BL
  • Microglia (metabolism)
  • Molecular Targeted Therapy
  • Peptide Fragments (metabolism)
  • Plaque, Amyloid (metabolism)
  • Protein Aggregation, Pathological
  • Sphingomyelin Phosphodiesterase (antagonists & inhibitors, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: